204 related articles for article (PubMed ID: 15229776)
41. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
42. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
[TBL] [Abstract][Full Text] [Related]
43. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
[TBL] [Abstract][Full Text] [Related]
44. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
[TBL] [Abstract][Full Text] [Related]
45. [Intraarterial injection therapy of CDDP-PC-lipiodol suspension for hepatoma].
Aikawa H; Mori H; Hirao K; Ajimu A; Iwao M; Hayashi K; Hombo Z; Ogasawara M; Nakashima M; Ichikawa M
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1585-9. PubMed ID: 2846720
[No Abstract] [Full Text] [Related]
46. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine.
Cho YD; Yum HY; Park YH
J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883
[TBL] [Abstract][Full Text] [Related]
47. [131-I-lipiodol in therapy of liver carcinoma--methods and case report].
Stefanović L; Nikolić V; Obradović M; Selir Z; Mihoci Z; Mihailović J; Malesević M
Med Pregl; 2001; 54(7-8):387-90. PubMed ID: 11905192
[TBL] [Abstract][Full Text] [Related]
48. Hepatocellular carcinoma; treatment with a radioiodinated fatty acid ester.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Choi HJ; Madsen MT
Yonsei Med J; 1988; 29(2):166-75. PubMed ID: 2851226
[No Abstract] [Full Text] [Related]
49. [Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
Ichikawa W; Nihei Z; Sawai S; Yamashita T; Uetake H; Kawachi Y; Hirayama R; Mishima Y; Tamaru H
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1550-2. PubMed ID: 1326920
[TBL] [Abstract][Full Text] [Related]
50. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
[TBL] [Abstract][Full Text] [Related]
51. [A case of advanced hepatocellular carcinoma effectively treated with 5-fluorouracil and high-concentration cisplatin suspended in lipiodol by short-term hepatic arterial infusion chemotherapy].
Yata Y; Kanda D; Takeuchi S; Hatanaka T; Iesaki K; Yoshinaga T; Kubota J; Higuchi T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1179-81. PubMed ID: 19620813
[TBL] [Abstract][Full Text] [Related]
52. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
53. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
54. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
[TBL] [Abstract][Full Text] [Related]
55. [Microscopic changes in the human liver after intra-arterial infusion of anticancer agents suspended in lipiodol].
Taniguchi H; Yamaguchi T; Kondo S; Shimotsuma M; Sawai K; Takahashi T; Hosokawa Y; Kamachi M; Ashihara T
Gan No Rinsho; 1988 Feb; 34(2):143-9. PubMed ID: 2450212
[TBL] [Abstract][Full Text] [Related]
56. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
57. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
58. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
59. 131I-Labelled-iodized oil for palliative treatment of hepatocellular carcinoma.
Borbath I; Lhommel R; Bittich L; Goffette P; Annet L; Van Beers BE; Bonny MA; Pauwels S; Horsmans Y
Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):905-10. PubMed ID: 16093866
[TBL] [Abstract][Full Text] [Related]
60. Lipiodol avid liver metastases from adrenocortical carcinoma; prospects for therapy?
Nye E; Butler P; Clingan PC; Morris DL
Anticancer Res; 2001; 21(2B):1445-7. PubMed ID: 11396229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]